The main objective for the ASMF procedure, commonly known as the European Drug Master File (EDMF) procedure, is to allow valuable confidential intellectual property or “know-how” of the manufacturer of active substance (ASM) to be protected while at the same time allowing the Applicant or marketing authorization holder to take full responsibility of the medicinal product and the quality and quality control of the active substance.
regaffairs.home.blog 